Global Rapid Antigen Testing Market Size, Status and Forecast 2021-2027

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Rapid Antigen Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 Immunosorbent Assay
  • 1.2.3 Enzyme-linked Immunosorbent
  • 1.2.4 Precipitation Reaction
  • 1.2.5 Radioimmunoassay
  • 1.2.6 Agglutination Reaction
  • 1.2.7 Complement Fixatio
• 1.3 Market by Application
  • 1.3.1 Global Rapid Antigen Testing Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Hospitals
  • 1.3.3 Specialty Clinics
  • 1.3.4 Diagnostic Centers
  • 1.3.5 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Rapid Antigen Testing Market Perspective (2016-2027)
• 2.2 Rapid Antigen Testing Growth Trends by Regions
  • 2.2.1 Rapid Antigen Testing Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 Rapid Antigen Testing Historic Market Share by Regions (2016-2021)
  • 2.2.3 Rapid Antigen Testing Forecasted Market Size by Regions (2022-2027)
• 2.3 Rapid Antigen Testing Industry Dynamic
  • 2.3.1 Rapid Antigen Testing Market Trends
  • 2.3.2 Rapid Antigen Testing Market Drivers
  • 2.3.3 Rapid Antigen Testing Market Challenges
  • 2.3.4 Rapid Antigen Testing Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Rapid Antigen Testing Players by Revenue
  • 3.1.1 Global Top Rapid Antigen Testing Players by Revenue (2016-2021)
  • 3.1.2 Global Rapid Antigen Testing Revenue Market Share by Players (2016-2021)
• 3.2 Global Rapid Antigen Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Rapid Antigen Testing Revenue
• 3.4 Global Rapid Antigen Testing Market Concentration Ratio
  • 3.4.1 Global Rapid Antigen Testing Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Rapid Antigen Testing Revenue in 2020
• 3.5 Rapid Antigen Testing Key Players Head office and Area Served
• 3.6 Key Players Rapid Antigen Testing Product Solution and Service
• 3.7 Date of Enter into Rapid Antigen Testing Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Rapid Antigen Testing Breakdown Data by Type

• 4.1 Global Rapid Antigen Testing Historic Market Size by Type (2016-2021)
• 4.2 Global Rapid Antigen Testing Forecasted Market Size by Type (2022-2027)

5 Rapid Antigen Testing Breakdown Data by Application

• 5.1 Global Rapid Antigen Testing Historic Market Size by Application (2016-2021)
• 5.2 Global Rapid Antigen Testing Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America Rapid Antigen Testing Market Size (2016-2027)
• 6.2 North America Rapid Antigen Testing Market Size by Type
  • 6.2.1 North America Rapid Antigen Testing Market Size by Type (2016-2021)
  • 6.2.2 North America Rapid Antigen Testing Market Size by Type (2022-2027)
  • 6.2.3 North America Rapid Antigen Testing Market Size by Type (2016-2027)
• 6.3 North America Rapid Antigen Testing Market Size by Application
  • 6.3.1 North America Rapid Antigen Testing Market Size by Application (2016-2021)
  • 6.3.2 North America Rapid Antigen Testing Market Size by Application (2022-2027)
  • 6.3.3 North America Rapid Antigen Testing Market Size by Application (2016-2027)
• 6.4 North America Rapid Antigen Testing Market Size by Country
  • 6.4.1 North America Rapid Antigen Testing Market Size by Country (2016-2021)
  • 6.4.2 North America Rapid Antigen Testing Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Rapid Antigen Testing Market Size (2016-2027)
• 7.2 Europe Rapid Antigen Testing Market Size by Type
  • 7.2.1 Europe Rapid Antigen Testing Market Size by Type (2016-2021)
  • 7.2.2 Europe Rapid Antigen Testing Market Size by Type (2022-2027)
  • 7.2.3 Europe Rapid Antigen Testing Market Size by Type (2016-2027)
• 7.3 Europe Rapid Antigen Testing Market Size by Application
  • 7.3.1 Europe Rapid Antigen Testing Market Size by Application (2016-2021)
  • 7.3.2 Europe Rapid Antigen Testing Market Size by Application (2022-2027)
  • 7.3.3 Europe Rapid Antigen Testing Market Size by Application (2016-2027)
• 7.4 Europe Rapid Antigen Testing Market Size by Country
  • 7.4.1 Europe Rapid Antigen Testing Market Size by Country (2016-2021)
  • 7.4.2 Europe Rapid Antigen Testing Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Rapid Antigen Testing Market Size (2016-2027)
• 8.2 Asia-Pacific Rapid Antigen Testing Market Size by Type
  • 8.2.1 Asia-Pacific Rapid Antigen Testing Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific Rapid Antigen Testing Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific Rapid Antigen Testing Market Size by Type (2016-2027)
• 8.3 Asia-Pacific Rapid Antigen Testing Market Size by Application
  • 8.3.1 Asia-Pacific Rapid Antigen Testing Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific Rapid Antigen Testing Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific Rapid Antigen Testing Market Size by Application (2016-2027)
• 8.4 Asia-Pacific Rapid Antigen Testing Market Size by Region
  • 8.4.1 Asia-Pacific Rapid Antigen Testing Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific Rapid Antigen Testing Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Rapid Antigen Testing Market Size (2016-2027)
• 9.2 Latin America Rapid Antigen Testing Market Size by Type
  • 9.2.1 Latin America Rapid Antigen Testing Market Size by Type (2016-2021)
  • 9.2.2 Latin America Rapid Antigen Testing Market Size by Type (2022-2027)
  • 9.2.3 Latin America Rapid Antigen Testing Market Size by Type (2016-2027)
• 9.3 Latin America Rapid Antigen Testing Market Size by Application
  • 9.3.1 Latin America Rapid Antigen Testing Market Size by Application (2016-2021)
  • 9.3.2 Latin America Rapid Antigen Testing Market Size by Application (2022-2027)
  • 9.3.3 Latin America Rapid Antigen Testing Market Size by Application (2016-2027)
• 9.4 Latin America Rapid Antigen Testing Market Size by Country
  • 9.4.1 Latin America Rapid Antigen Testing Market Size by Country (2016-2021)
  • 9.4.2 Latin America Rapid Antigen Testing Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Rapid Antigen Testing Market Size (2016-2027)
• 10.2 Middle East & Africa Rapid Antigen Testing Market Size by Type
  • 10.2.1 Middle East & Africa Rapid Antigen Testing Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa Rapid Antigen Testing Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa Rapid Antigen Testing Market Size by Type (2016-2027)
• 10.3 Middle East & Africa Rapid Antigen Testing Market Size by Application
  • 10.3.1 Middle East & Africa Rapid Antigen Testing Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa Rapid Antigen Testing Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa Rapid Antigen Testing Market Size by Application (2016-2027)
• 10.4 Middle East & Africa Rapid Antigen Testing Market Size by Country
  • 10.4.1 Middle East & Africa Rapid Antigen Testing Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa Rapid Antigen Testing Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Abbott Laboratories
  • 11.1.1 Abbott Laboratories Company Details
  • 11.1.2 Abbott Laboratories Business Overview
  • 11.1.3 Abbott Laboratories Rapid Antigen Testing Introduction
  • 11.1.4 Abbott Laboratories Revenue in Rapid Antigen Testing Business (2016-2021)
  • 11.1.5 Abbott Laboratories Recent Development
• 11.2 F. Hoffmann-La Roche
  • 11.2.1 F. Hoffmann-La Roche Company Details
  • 11.2.2 F. Hoffmann-La Roche Business Overview
  • 11.2.3 F. Hoffmann-La Roche Rapid Antigen Testing Introduction
  • 11.2.4 F. Hoffmann-La Roche Revenue in Rapid Antigen Testing Business (2016-2021)
  • 11.2.5 F. Hoffmann-La Roche Recent Development
• 11.3 Oxford BioMedica
  • 11.3.1 Oxford BioMedica Company Details
  • 11.3.2 Oxford BioMedica Business Overview
  • 11.3.3 Oxford BioMedica Rapid Antigen Testing Introduction
  • 11.3.4 Oxford BioMedica Revenue in Rapid Antigen Testing Business (2016-2021)
  • 11.3.5 Oxford BioMedica Recent Development
• 11.4 Affinity Biologicals
  • 11.4.1 Affinity Biologicals Company Details
  • 11.4.2 Affinity Biologicals Business Overview
  • 11.4.3 Affinity Biologicals Rapid Antigen Testing Introduction
  • 11.4.4 Affinity Biologicals Revenue in Rapid Antigen Testing Business (2016-2021)
  • 11.4.5 Affinity Biologicals Recent Development
• 11.5 Epitope Diagnostics
  • 11.5.1 Epitope Diagnostics Company Details
  • 11.5.2 Epitope Diagnostics Business Overview
  • 11.5.3 Epitope Diagnostics Rapid Antigen Testing Introduction
  • 11.5.4 Epitope Diagnostics Revenue in Rapid Antigen Testing Business (2016-2021)
  • 11.5.5 Epitope Diagnostics Recent Development
• 11.6 Sino Biological
  • 11.6.1 Sino Biological Company Details
  • 11.6.2 Sino Biological Business Overview
  • 11.6.3 Sino Biological Rapid Antigen Testing Introduction
  • 11.6.4 Sino Biological Revenue in Rapid Antigen Testing Business (2016-2021)
  • 11.6.5 Sino Biological Recent Development
• 11.7 R-Biopharma
  • 11.7.1 R-Biopharma Company Details
  • 11.7.2 R-Biopharma Business Overview
  • 11.7.3 R-Biopharma Rapid Antigen Testing Introduction
  • 11.7.4 R-Biopharma Revenue in Rapid Antigen Testing Business (2016-2021)
  • 11.7.5 R-Biopharma Recent Development
• 11.8 Cell Biolabs
  • 11.8.1 Cell Biolabs Company Details
  • 11.8.2 Cell Biolabs Business Overview
  • 11.8.3 Cell Biolabs Rapid Antigen Testing Introduction
  • 11.8.4 Cell Biolabs Revenue in Rapid Antigen Testing Business (2016-2021)
  • 11.8.5 Cell Biolabs Recent Development
• 11.9 Thermo Fisher Scientific
  • 11.9.1 Thermo Fisher Scientific Company Details
  • 11.9.2 Thermo Fisher Scientific Business Overview
  • 11.9.3 Thermo Fisher Scientific Rapid Antigen Testing Introduction
  • 11.9.4 Thermo Fisher Scientific Revenue in Rapid Antigen Testing Business (2016-2021)
  • 11.9.5 Thermo Fisher Scientific Recent Development
• 11.10 Bio-Rad Laboratories
  • 11.10.1 Bio-Rad Laboratories Company Details
  • 11.10.2 Bio-Rad Laboratories Business Overview
  • 11.10.3 Bio-Rad Laboratories Rapid Antigen Testing Introduction
  • 11.10.4 Bio-Rad Laboratories Revenue in Rapid Antigen Testing Business (2016-2021)
  • 11.10.5 Bio-Rad Laboratories Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer